Frankfurt
02.10.26 | 21:45
1,660 Euro
+11,41 % +0,170
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MAYNE PHARMA GROUP Aktie jetzt für 0€ handeln | |||||
| Mi | Daily Special: INOVIQ, Immutep, First Graphene, Mayne Pharma, Vitrafy Life Sciences | 21 | Finance News Network | ||
| Mi | Mayne Pharma Settles IMVEXXY Patent Litigation With Sun Pharma | 273 | AFX News | CANBERA (dpa-AFX) - Mayne Pharma Group Limited (MYX.AX) has reached settlement with Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS), resolving the Paragraph 1V patent litigation concerning... ► Artikel lesen | |
| Mi | MAYNE PHARMA GROUP LIMITED: MYX settles US patent litigation re Imvexxy with Sun Pharma | 2 | ASX | ||
| Mo | MAYNE PHARMA GROUP LIMITED: Mayne Pharma announces legal settlement | 1 | ASX | ||
| Mo | MAYNE PHARMA GROUP LIMITED: Date for Annual General Meeting | 2 | ASX | ||
| 15.09. | MAYNE PHARMA GROUP LIMITED: MYX signs licence agreement for Blissel in Australia | - | ASX | ||
| 08.09. | MAYNE PHARMA GROUP LIMITED: Notification of cessation of securities - MYX | 1 | ASX | ||
| 08.09. | MAYNE PHARMA GROUP LIMITED: Notification regarding unquoted securities - MYX | - | ASX | ||
| 28.08. | MAYNE PHARMA GROUP LIMITED: Application for quotation of securities - MYX | - | ASX | ||
| 27.08. | Mayne Pharma Group reports FY results | 1 | Seeking Alpha | ||
| 27.08. | Mayne Pharma FY26 slides: margins expand despite revenue decline | 1 | Investing.com | ||
| 27.08. | MAYNE PHARMA GROUP LIMITED: 2026 Full Year Results Investor Presentation | 2 | ASX | ||
| 27.08. | MAYNE PHARMA GROUP LIMITED: 2026 Corporate Governance Statement and Appendix 4G | 1 | ASX | ||
| 27.08. | MAYNE PHARMA GROUP LIMITED: 2026 Full Year Results Media Release | 1 | ASX | ||
| 27.08. | MAYNE PHARMA GROUP LIMITED: 2026 Appendix 4E and Annual Report | 1 | ASX | ||
| 21.08. | MAYNE PHARMA GROUP LIMITED: Notification of date for release of FY26 results | - | ASX | ||
| 20.08. | MAYNE PHARMA GROUP LIMITED: Upcoming presentation of Imvexxy clinical data | - | ASX | ||
| 18.08. | MAYNE PHARMA GROUP LIMITED: Mayne Pharma launches Investor Hub | 1 | ASX | ||
| 14.08. | MAYNE PHARMA GROUP LIMITED: Initial Director's Interest Notice | 1 | ASX | ||
| 05.08. | MAYNE PHARMA GROUP LIMITED: Mayne Pharma Bioshares Summit Presentation | - | ASX |
1 2 3 Weiter >>
58 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 33,210 | -0,48 % | Novo Nordisk gerät trotz GLP-1 unter Druck - warum Eli Lilly und Co. schon Milliarden in neue Plattformen investieren | ||
| PFIZER | 24,735 | +0,18 % | Litfulo and tilrekimig data bolster Pfizer's immunology plans | ||
| MERCK KGAA | 136,90 | +1,82 % | Merck Aktie | Wichtige Durchschnittslinien durchbrochen | Analyse | ||
| AURORA CANNABIS | 3,518 | +0,86 % | Aurora Cannabis: Beschwerde bringt den Deal ins Wanken | ||
| CANOPY GROWTH | 0,780 | +0,72 % | Canopy Growth Corporation: Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany | Mr. Blöte's appointment strengthens Canopy Growth's commercial leadership as it drives growth across its European medical cannabis businessCanopy Growth Corporation ("Canopy Growth", "our", "we" or... ► Artikel lesen | |
| ASTRAZENECA | 139,30 | 0,00 % | Summit to Pair with AstraZeneca, Daiichi Sankyo to Evaluate Ivonescimab as Combination Therapy | ||
| TILRAY BRANDS | 3,215 | +0,31 % | Tilray Brands, Inc.: BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team | New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray BrandsELLON, Scotland and LONDON, Sept. 28, 2026... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 448,45 | +0,04 % | $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE... ► Artikel lesen | |
| CRONOS GROUP | 2,896 | +1,05 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| VIATRIS | 15,400 | -1,52 % | Dividendenbekanntmachungen (21.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,0642 EUR ALLISON TRANSMISSION HOLDINGS INC US01973R1014 0,29 USD 0,2483 EUR AMGEN... ► Artikel lesen | |
| DIGICANN VENTURES | 0,007 | -26,32 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,837 | -1,06 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 5,880 | -0,51 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SINOPHARM | 1,649 | 0,00 % | Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen |
MAYNE PHARMA GROUP LIMITED gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von +0,170 (+11,41 %) liegt der Kurs bei 1,660 Euro. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MAYNE PHARMA GROUP LIMITED finden Sie auf Wallstreet Online.